Firm
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Sponsored
Sponsored
-
Sponsored by Bird & BirdEwan Grist of Bird & Bird considers the important questions that courts in both the EU and UK need to answer for their unregistered design regimes -
Sponsored by Tilleke & GibbinsChi Lan Dang of Tilleke & Gibbins considers why a straw man is being commonly used and has become familiar to trademark practitioners in Vietnam
-
Sponsored by OLIVARESArmando Arenas of Olivares explores how Mexico has interpreted the experimental and academic use exception
-
Sponsored by Cabinet Beau de LoménieBeau de Loménie explain the timelines set out in France for the release of court rulings to the public, although further patience is required in concern of first instance decisions
-
Sponsored by Spoor & FisherMatthew Costard of Spoor & Fisher explains why the Gambia’s ‘British law’ legacy is a cause of concern for ARIPO trademarks
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law explains how the recent Supreme Court en banc ruling changes precedents on infringement by the use of later-registered trademarks
